Instil Bio, Inc.

Biotechnology • Healthcare • Dallas, TX, United States • TIL (NCM)

Instil Bio, Inc., a clinical-stage biopharmaceutical company, focuses on developing a pipeline of novel therapies. Its lead products candidate is AXN-2510/IMM2510 that is in Phase 1b/2 clinical trial for the treatment of patients with chemotherapy in patients with advanced/metastatic non-small cell lung cancer. The company also conducts a Phase 1 open label trial in China for AXN-2510/IMM2510 as monotherapy in patients with advanced solid tumors, including triple-negative breast cancer, squamous non-small cell lung cancer, hepatocellular carcinoma, renal cell carcinoma, and rare solid tumors, such as soft tissue sarcomas and thymic cancer. Instil Bio, Inc. was incorporated in 2018 and is headquartered in Dallas, Texas.

972 499 3350 3963 Maple Avenue, Dallas, TX 75219, United States

Stock Performance (90 Days)

Data through Dec 26, 2025

Price updates on page refresh. Intraday quotes available during market hours (9:30 AM - 4:00 PM EST).

Layoff History

No layoff events recorded for this company.

Recent News

Instil Bio (TIL) Price Target Increased by 41.50% to 97.66 - Nasdaq

Nasdaq • Oct 29

Wall Street Analysts Think Instil Bio (TIL) Could Surge 246.68%: Read This Before Placing a Bet - Yahoo Finance

Yahoo Finance • Jun 16

Instil Bio Reports Third Quarter 2025 Financial Results and Provides Corporate Update - GlobeNewswire

GlobeNewswire • Nov 13

Citizens reiterates Market Perform rating on Instil Bio stock - Investing.com

Investing.com • Nov 18

Instil Bio: Chasing After Summit And BioNTech, Albeit With Some Hiccups - Seeking Alpha

Seeking Alpha • Jun 30

Other Biotechnology Companies

Vertex Pharmaceuticals Inc. / MA

$118.68B market cap

Regeneron Pharmaceuticals, Inc.

$82.72B market cap

Alnylam Pharmaceuticals, Inc.

Frequently Asked Questions

Has Instil Bio, Inc. had layoffs?

No layoff events have been recorded for Instil Bio, Inc. in our database. This could mean the company has not conducted significant layoffs, or any layoffs have not been publicly reported.

How many employees does Instil Bio, Inc. have?

Instil Bio, Inc. has approximately 14 employees.

What industry is Instil Bio, Inc. in?

Instil Bio, Inc. operates in the Biotechnology industry, within the Healthcare sector.

Is Instil Bio, Inc. a publicly traded company?

Yes, Instil Bio, Inc. is publicly traded under the ticker symbol TIL on the NCM. The company has a market capitalization of approximately $0.08 billion.

Where is Instil Bio, Inc. headquartered?

Instil Bio, Inc. is headquartered in Dallas, TX, United States at 3963 Maple Avenue, Dallas, TX 75219, United States.

Disclaimer

Data aggregated from public sources including WARN notices, SEC filings, press releases, and market data. While we strive for accuracy, information is provided "as-is" for informational purposes only. Always verify critical information with official company sources.

This information does not constitute investment, financial, legal, or career advice. See our Terms of Service, Privacy Policy, and About page for more information.

Found an error? Report it here.